Evidence map›Paper›PMID 28059759›Full record

ArticleScience (New York, N.Y.)2017

A global view of meiotic double-strand break end resection.

Eleni P Mimitou, Shintaro Yamada, Scott Keeney

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 125 papers.

0numbers the graph read from it
0cells of the map it votes in
125citing papers in PubMed
9.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

125 citing papers in PubMed, 193 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Mechanisms That Govern Recombinase Fidelity Control During Eukaryotic Homologous Recombination.BioEssays : news and reviews in molecular, cellular and developmental biology · 2026
    Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. bioRxiv : the preprint server for biology · 2026
    Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

65 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Eleni P MimitouMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Shintaro YamadaMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.
Scott KeeneyMolecular Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA. s-keeney@ski.mskcc.org.
Memorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Mechanism and regulation of meiotic recombinationR35GM118092 · NIGMS · SLOAN-KETTERING INST CAN RESEARCH · PI Scott Keeney · 2016 to 2026
$7.0M
Mechanism of meiotic recombination in yeastR01GM058673 · NIGMS · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI KEENEY, SCOTT · 1999 to 2015
$6.0M
NCI NIH HHS P30 CA008748NIGMS NIH HHS R01 GM058673NIGMS NIH HHS R35 GM118092
6 · The paper itself

Abstract

DNA double-strand breaks that initiate meiotic recombination are exonucleolytically processed. This 5'→3' resection is a central, conserved feature of recombination but remains poorly understood. To address this lack, we mapped resection endpoints genome-wide at high resolution in Saccharomyces cerevisiae Full-length resection requires Exo1 exonuclease and the DSB-responsive kinase Tel1, but not Sgs1 helicase. Tel1 also promotes efficient and timely resection initiation. Resection endpoints display pronounced heterogeneity between genomic loci that reflects a tendency for nucleosomes to block Exo1, yet Exo1 also appears to digest chromatin with high processivity and at rates similar to naked DNA in vitro. This paradox points to nucleosome destabilization or eviction as a defining feature of the meiotic resection landscape.

Indexed as

DNA Breaks, Double-StrandedHomologous RecombinationMeiosisChromatinExodeoxyribonucleasesGenetic LociIntracellular Signaling Peptides and ProteinsNucleosomesProtein Serine-Threonine KinasesRecQ HelicasesSaccharomyces cerevisiaeSaccharomyces cerevisiae ProteinsChromatinexodeoxyribonuclease IExodeoxyribonucleasesIntracellular Signaling Peptides and ProteinsNucleosomesProtein Serine-Threonine KinasesRecQ HelicasesSaccharomyces cerevisiae ProteinsSGS1 protein, S cerevisiaeTEL1 protein, S cerevisiae

Identifiers

PMID28059759
PMCPMC5234563
OpenAlexW2570792050

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.